SRE
45
-7
MMM
28
-5
MMC
53
-5
PFG
58
10
EXPE
69
2
CMI
65
-2
AIZ
57
-7
BXP
44
-3
EXC
47
-4
CPB
35
-5
D
33
-2
COST
69
2
FITB
50
-2
MUR
38
-6
CMS
60
-5
URI
66
-2
SIG
49
-3
PFE
40
8
ABBV
68
-2
USB
42
-4
SRE
45
-7
MMM
28
-5
MMC
53
-5
PFG
58
10
EXPE
69
2
CMI
65
-2
AIZ
57
-7
BXP
44
-3
EXC
47
-4
CPB
35
-5
D
33
-2
COST
69
2
FITB
50
-2
MUR
38
-6
CMS
60
-5
URI
66
-2
SIG
49
-3
PFE
40
8
ABBV
68
-2
USB
42
-4
Financhill
Back

Spyre Therapeutics Stock Predictions

The Next Nvidia?

Go here now for this breaking story.
Sell
27

SYRE
Spyre Therapeutics

Last Price:
22.97
Seasonality Move:
49.76%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 77.3% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 77.3% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
27
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
8.43

Prediction Charts

Market Cap:
922.49M
Price in USD:
22.90
Volume:
546.26K
Beta:
2.60

Technical Analysis

SMA50:
33.73
SMA100:
33.16
SMA200:
24.46
52-Wk Change:
129%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 22.90 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-5 34.12 35.13 35.34 33.85
Jun-6 35.43 34.61 35.89 33.37
Jun-7 34.09 33.67 35.79 33.09
Jun-10 33.78 36.47 36.97 33.58
Jun-11 36.04 37.98 38.22 35.14
Jun-12 38.51 37.00 38.90 36.81
Jun-13 36.77 32.36 36.77 30.99
Jun-14 31.78 31.51 32.60 30.74
Jun-17 31.62 25.43 32.00 24.00
Jun-18 25.25 25.79 26.30 24.47
Jun-20 25.75 25.63 26.55 24.41
Jun-21 25.88 24.12 26.54 23.78
Jun-24 23.94 24.14 24.40 23.00
Jun-25 24.11 22.90 24.77 22.63

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.